TAFOLECIMAB
UNII KV2ZKH0NIM

Substance Identification & Data

This profile provides standardized clinical and technical data for Tafolecimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KV2ZKH0NIM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2225109-03-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

KV2ZKH0NIM

CAS Registry Number

2225109-03-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TAFOLECIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C171839

National Cancer Institute reference terminology for clinical and research data.

INN ID

11061

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tafolecimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TAFOLECIMAB

Common Names & Synonyms

IMMUNOGLOBULIN IGG2, ANTI-(HUMAN PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9) (HUMAN MONOCLONAL IBI306 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IBI306 .KAPPA.-CHAIN, DIMER

TAFOLECIMAB [INN]

TAFOLECIMAB [WHO-DD]